Adiponectin: A New Independent Predictor of Liver Steatosis and Response to IFN-α Treatment in Chronic Hepatitis C

Department of Medicine (Research Laboratory of Internal Medicine), Medical School, University of Thessaly, Larissa, Greece.
The American Journal of Gastroenterology (Impact Factor: 10.76). 03/2008; 103(3):605-14. DOI: 10.1111/j.1572-0241.2007.01729.x
Source: PubMed


To compare serum adiponectin and tumor necrosis factor (TNF)-alpha among patients with viral liver diseases; to investigate associations of serum adiponectin and TNF-alpha with histological or viral characteristics of chronic hepatitis C (CHC); to investigate adiponectin and TNF-alpha alterations during interferon (IFN)-alpha treatment; and to assess the relationship between serum adiponectin and TNF-alpha and response rates to treatment.
Adiponectin (mug/mL) and TNF-alpha (pg/mL) determinations by enzyme-linked immunosorbent assay (ELISA) in serial samples (before, the middle, the end, and 6 months after the end of treatment) from 83 CHC and 59 chronic hepatitis B (CHB) patients. Forty-three blood donors served as healthy controls. Patients were treated with IFN-alpha (4.5 MU/t.i.w.) for 12 months in CHB cases, and IFN-alpha (3 MU/t.i.w.) plus ribavirin for 6-12 months according to hepatitis C virus (HCV) genotype in CHC cases.
After adjustment for gender and body mass index (BMI), HCV genotype 3 overweight patients (BMI > 25 kg/m(2)) had significantly lower adiponectin (7.3 +/- 2.7) at baseline compared with non-3 HCV genotype overweight patients (P < 0.05). Lower adiponectin (HCV genotype 3, P= 0.02 and HCV genotype 1, P= 0.025) and higher TNF-alpha (P= 0.025) at baseline were identified as independent predictors of liver steatosis in CHC patients. Lower adiponectin was also identified as an independent predictor of no virological response at the end of treatment (odds ratio [OR] 0.76, 95% confidence interval [CI] 0.66-0.87, P < 0.001). At the end of IFN-alpha therapy, only HCV genotype 3 patients had significantly higher serum adiponectin (10.4 +/- 6.3) compared with its levels before treatment (8.7 +/- 4.7, P < 0.05).
This study suggests that HCV genotype 3 may directly affect adiponectin. This is further supported by the significant increase in adiponectin at the end of treatment only in HCV genotype 3 patients. Serum adiponectin at baseline appears to be an independent predictor of liver steatosis and for the achievement of end-of-treatment virological response, while serum TNF-alpha at baseline was identified as an independent predictor only of liver steatosis.

7 Reads
  • [Show abstract] [Hide abstract]
    ABSTRACT: A microstrip-to-waveguide microwave transition is analysed via the application of an efficient hybrid modal expansion/finite element method. The method relies on the knowledge of a modal expansion at each junction port. This expansion is analytically known in the waveguide and is numerically computed in the microstrip region via an appropriate finite element method application. Higher order bases are exploited
    Antennas and Propagation Society International Symposium, 2001. IEEE; 02/2001
  • [Show abstract] [Hide abstract]
    ABSTRACT: This paper deals with the problem of robustly stabilizing a linear time-invariant plant in the presence of uncertain time delay. We define the delay margin to be the largest time delay such that, for any delay less than this value, the closed-loop system is stable. We show that the delay margin can be made arbitrarily large by using a linear time-varying controller.
    Decision and Control, 2002, Proceedings of the 41st IEEE Conference on; 01/2003
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Adipose tissue is a massive source of bioactive substances known as adipocytokines, including tumor necrosis factor (TNF)-alpha, resistin, leptin, and adiponectin. Recent advances in medical research view obesity as a chronic low-grade inflammatory state. Hypertrophied adipocytes in obesity release chemokines that induce macrophage accumulation in adipose tissue. Accumulated macrophages in obese adipose tissue produce proinflammatory cytokines and nitric oxide, and these inflammatory changes induce adipocytokine dysregulation. The latter is characterized by a decrease in insulinsensitizing and anti-inflammatory adipocytokines, and an increase in proinflammatory adipocytokines. Adipocytokine dysregulation induces obesity-related metabolic disorders, the so-called metabolic syndrome. Metabolic syndrome is a cluster of metabolic abnormalities, including diabetes mellitus, hypertension, hyperlipidemia, and nonalcoholic steatohepatitis (NASH). Recent studies have revealed that obesity is an independent risk factor for chronic liver diseases, such as NASH, alcoholic liver disease, chronic hepatitis C, and hepatocellular carcinoma. A common mechanism underlying these hepatic clinical states is thought to be adipocytokine dysregulation. In this review, we discuss the association of adipocytokines, especially leptin, adiponectin, TNF-alpha, and resistin, with liver diseases.
    Journal of Gastroenterology 02/2008; 43(11):811-22. DOI:10.1007/s00535-008-2213-6 · 4.52 Impact Factor
Show more